Fund HoldingsDecheng Capital LLC

Total Portfolio Value
$422.19M
Total Bought
$100.33M
Total Sold
$1.15M
Net Transaction
+$99.18M
Filing Period:
Securities
SharesValue ($K)
Q2 2024
Q3 2024
Change
Q2 2024
Q3 2024
Weight (%)
Change
Nuvation Bio Inc.(NUVB)6,950,23925,954,439+19,004,20020,29559,43614.08%+39,141
CG ONCOLOGY INC(CGON)5,458,8105,478,810+20,000172,335206,71648.96%+34,381
PHATHOM PHARMACEUTICALS INC(PHAT)850,0001,250,000+400,0008,75522,6005.35%+13,845
NEWAMSTERDAM PHARMA CO NV
ORDINARY SHARES
400,000590,000+190,0007,6849,7942.32%+2,110
LONGBOARD PHARMACEUTICALS IN056,350+56,35001,8780.44%+1,878
ARCELLX INC
COMMON STOCK
1,17721,177+20,000651,7680.42%+1,704
GeneDx Holdings Corp.(WGS)103,604103,60402,7084,3971.04%+1,689
MOONLAKE IMMUNOTHERAPEUTICS166,600166,60007,3258,4001.99%+1,075
Illumnia, Inc.(ILMN)108,76794,767-14,00011,35312,3592.93%+1,005
CRINETICS PHARMACEUTICALS IN(CRNX)157,958157,95807,0758,0721.91%+997
KRYSTAL BIOTECH INC(KRYS)65,77271,772+6,00012,07813,0653.09%+986
LEGEND BIOTECH CORP-ADR(LEGN)98,558108,558+10,0004,3655,2901.25%+925
Aura Biosciences, Inc.515,555515,55503,8984,5941.09%+696
Equillium Inc.4,447,3084,447,30803,0833,7000.88%+617
VERA THERAPEUTICS INC(VERA)69,76769,76702,5243,0840.73%+560
AtriCure Inc.(ATRC)26,79726,79706107510.18%+141
Pyxis Oncology, Inc (formerly Apexigen)326,810326,81001,0821,1990.28%+118
REVOLUTION MEDICINES INC(NSM)(RVMD)02,000+2,0000910.02%+91
Arcus Biosciences, Inc(RCUS)869,790869,790013,24713,2993.15%+52
Nuvation Bio Inc.(NUVB)646,057646,0570103630.01%-40
CYTOKINETICS INC(CYTK)94,04394,04305,0954,9651.18%-130
GRAIL INC(GRAL)18,1279,684-8,4432791330.03%-145
BeyondSpring Inc.4,958,1434,958,143011,90011,3542.69%-545
Zentalis Pharmaceuticals Inc.3,070,4423,108,095+37,65312,55811,4382.71%-1,120
MERUS NV179,098189,098+10,00010,5979,4472.24%-1,150
4D MOLECULAR THERAPEUTICS IN347,835397,835+50,0007,3014,3011.02%-3,000
Page 1 of 1